Viciana-Fernández Pompeyo, Falcó Vicenç, Castaño Manuel, de los Santos-Gil Ignacio, Olalla-Sierra Julián, Hernando Asunción, Deig Elisabet, Clotet Bonaventura, Knobel Hernando, Podzamczer Daniel, Pedrol Pere Domingo
Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocío, Sevilla, España.
Servicio de Enfermedades Infecciosas, Hospital Universitario Vall d'Hebrón, Barcelona, España.
Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):397-403. doi: 10.1016/j.eimc.2014.06.012. Epub 2015 Jan 7.
In Spain, HIV treatment guidelines are well known and generally followed. However, in some patients there are no plans to initiate ART despite having treatment indications. The current barriers to ART initiation are presented.
A cross-sectional survey including every HIV infected patient in care in 19 hospitals across Spain in 2012, with ≥1 indication to start ART according to 2011 national treatment guidelines, who had not been scheduled for ART initiation. Reasons for deferring treatment were categorized as follows (non-exclusive categories): a) The physician thinks the indication is not absolute and prefers to defer it; b) The patient does not want to start it; c) The physician thinks ART must be started, but there is some limitation to starting it, and d) The patient has undetectable viral load in absence of ART.
A total of 256 patients, out of 784 originally planned, were included. The large majority (84%) were male, median age 39 years, 57% MSM, 24% heterosexuals, and 16% IDUs. Median time since HIV diagnosis was 3 years, median CD4 count, 501 cells/mm3, median viral load 4.4 log copies/ml. Main ART indications were: CD4 count <500 cells/mm(3), 48%; having an uninfected sexual partner, 28%, and hepatitis C coinfection, 23%. Barriers due to, the physician, 55%; the patient, 28%; other limitations, 23%; and undetectable viral load, 6%.
The majority of subjects with ART indication were on it. The most frequent barriers among those who did not receive it were physician-related, suggesting that the relevance of the conditions that indicate ART may need reinforcing.
在西班牙,HIV治疗指南广为人知且普遍得到遵循。然而,在一些患者中,尽管有治疗指征,但仍未制定启动抗逆转录病毒治疗(ART)的计划。本文呈现了当前启动ART的障碍。
一项横断面调查纳入了2012年西班牙19家医院中每一位接受治疗的HIV感染患者,这些患者根据2011年国家治疗指南有≥1条启动ART的指征,但尚未安排启动ART。推迟治疗的原因分类如下(非排他性类别):a)医生认为指征并非绝对,倾向于推迟;b)患者不想开始治疗;c)医生认为必须开始ART,但启动存在一些限制;d)患者在未接受ART的情况下病毒载量不可检测。
最初计划纳入的784名患者中,共纳入了256名。绝大多数(84%)为男性,中位年龄39岁,57%为男男性行为者,24%为异性恋者,16%为注射吸毒者。自HIV诊断以来的中位时间为3年,中位CD4细胞计数为501个/mm³,中位病毒载量为4.4 log拷贝/ml。主要的ART指征为:CD4细胞计数<500个/mm³,占48%;有未感染的性伴侣,占28%;合并丙型肝炎感染,占23%。因医生导致的障碍占55%;因患者导致的障碍占28%;其他限制占23%;病毒载量不可检测占6%。
大多数有ART指征的受试者正在接受治疗。未接受治疗的患者中最常见的障碍与医生有关,这表明可能需要强化ART指征条件的相关性。